Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Autogenous Demineralized Dentin Graft (ADDG) is an autologous biomaterial developed and investigated by researchers at Cairo University for use in regenerative dentistry. It is prepared from a patient's own freshly extracted teeth, which are cleaned, ground into particles, and demineralized using 0.6N hydrochloric acid. This process preserves the organic matrix, primarily Type I collagen, and endogenous growth factors such as bone morphogenetic proteins (BMPs), while removing the mineral phase to enhance the release of these inductive signals. The material serves as an osteoconductive and osteoinductive scaffold, promoting bone formation in periodontal intrabony defects and alveolar ridge preservation sites. It is being evaluated as a cost-effective and biocompatible alternative to autogenous bone grafts.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Autogenous Demineralized Dentin Graft-Cairo University.